Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Levetiracetam |
Active Ingredient: | Levetiracetam 250mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Lupin Limited, Verna, India |
Product: | Levetiracetam |
Active Ingredient: | Levetiracetam 500mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Lupin Limited, Verna, India |
Product: | Levetiracetam |
Active Ingredient: | Levetiracetam 750mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Lupin Limited, Verna, India |
Product: | Levetiracetam |
Active Ingredient: | Levetiracetam 1000mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Lupin Limited, Verna, India |
Product: | Pantoprazole-AFT |
Active Ingredient: | Pantoprazole sodium sesquihydrate 45.1mg equivalent to pantoprazole 40mg |
Dosage Form: | Powder for injection |
New Zealand Sponsor: | AFT Pharmaceuticals Limited |
Manufacturer: | Hainan Poly Pharma Co. Limited, Haikou, China |
Dated this 29th day of July 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).